Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

Clinical trial NCT01214096 · TERMINATED

Trial details

NCT number: NCT01214096
Sponsor: Zensun Sci. & Tech. Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Heart Failure

Start date: 2010-07-01
Primary completion: 2011-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.